Pifexole
CAS: 27199-40-2
Ref. 3D-CBA19940
| 1g | A consultar | ||
| 5g | A consultar | ||
| 10g | A consultar | ||
| 250mg | A consultar | ||
| 500mg | A consultar |
Informação sobre produto
Pifexole is a potent anticancer drug that acts as an inhibitor of cyclin-dependent kinases (CDKs) and protein kinase B (AKT). This drug has been shown to induce apoptosis in cancer cells and inhibit tumor growth. Pifexole is derived from a Chinese medicinal plant, and its analog has been found in human urine. It targets CDKs and AKT, which are involved in the regulation of cell cycle progression and survival, respectively. Pifexole inhibits these enzymes, leading to cell death and preventing further growth of cancer cells. This drug has shown promising results in preclinical studies for various types of cancers, including breast, lung, and prostate cancer. Additionally, Pifexole has minimal toxicity compared to other anticancer drugs currently available on the market. Overall, Pifexole is a promising new therapy for cancer treatment with potential for significant impact on patient outcomes.
Propriedades químicas
Consulta técnica sobre: 3D-CBA19940 Pifexole
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
